Post-Doctoral Research Fellow : Boston, MA, United States
Our team, led by Dr. Ramnik Xavier, aim to understand the determinants of mucosal tolerance and immunity. To this end, our lab is using a combination of physiologically relevant cell-based assays, genome editing, novel mouse models, and computational analyses.
We are looking for postdoctoral associates to identify the components of the innate and adaptive immune systems that interact dynamically in human health and disease. Recent studies in our group have uncovered a novel role for CLEC12A as an early adaptor molecule in antibacterial autophagy (PMID: 26095365); used a CARD9 rare variant, that confers protection against inflammation, to uncover a TRIM62-mediated mechanism for regulation of CARD9 activation (PMID: 26488816); and identified DYRK1A as a physiologically relevant regulator of regulatory T cell differentiation (PMID: 25998054).
Current projects include (1) generate novel mouse models using cutting edge technologies, such asCRISPR, to uncover mechanisms of pathogenesis by inducing inflammation using infectious, non-infectious, and immune cell transfer models; (2) perform functional genomic screens to place disease-associated genetic variants in pathways; (3) examine the interactions between host genetics and the microbiome during inflammation; and (4) determine the role of novel autophagy genes in antibacterial defenses in vivo, as well as characterizing cell-specific functions of those genes.
Requirements
• Ph.D. or M.D./Ph.D. in immunology, cell biology or molecular biology
• Maximum 0-2 years of related postdoc experience preferred
• Well versed in the application of mouse models
• Strong publication record in high-impact journals
• Excellent communication skills and the ability
為防止簡(jiǎn)歷投遞丟失請(qǐng)抄送一份至：boshijob@126.com（郵件標(biāo)題格式：應(yīng)聘職位名稱+姓名+學(xué)歷+專業(yè)+中國(guó)博士人才網(wǎng)）
中國(guó)-博士人才網(wǎng)發(fā)布
聲明提示：凡本網(wǎng)注明“來源：XXX”的文/圖等稿件，本網(wǎng)轉(zhuǎn)載出于傳遞更多信息及方便產(chǎn)業(yè)探討之目的，并不意味著本站贊同其觀點(diǎn)或證實(shí)其內(nèi)容的真實(shí)性，文章內(nèi)容僅供參考。
